New Report by Project CBD Provides an In-Depth Primer on Cannabinoid Drug Interactions
Project CBD has published its in-depth Primer on Cannabinoid-Drug Interactions for health professionals, patients, and public policy-makers.
Study: Marijuana use and short-term outcomes in patients hospitalized for acute myocardial infarction
The aim of this retrospective study was to quantify short-term outcomes in marijuana-using and non-using patients hospitalized with AMI.
New Study Suggests Cannabis Use May Increase Survival Rate Among Heart Attack Patients
According to the study authors, cannabis users are significantly less likely to die folling an acute myocardial infarction than non-cannabis users
White Paper Explains How New Jersey Cannabis Can Close State Budget Gap
As lawmakers deliberate about the potential for a New Jersey cannabis program, closing the state’s budget gap is one of many advantages worth considering. Upon the release of its White…
Volunteers and Veterans Sought to Participate in Groundbreaking Cannabis PTSD Research Study
Researchers conducting a study on cannabis as a treatment for PTSD are seeking U.S. Military veterans to participate in a controlled clinical trial.
NAS Study Validates Marijuana As Medicine, Exposes Dire Need for Research
As the first comprehensive study to be conducted by a Federally sanctioned institution, the NAS study has potential to expose the fallacy of the classification of cannabis as a Schedule 1 controlled substance.
Amyloid proteotoxicity ….inflammatory response blocked by cannabinoid receptors
This study indicates likelihood that autocatalytic inflammatory response within nerve cells can be blocked by the activation of cannabinoid receptors.
The antitumor activity of plant-derived non-psychoactive cannabinoids
This review centers on mechanisms by which CBD inhibits tumor cell viability, invasion, metastasis, angiogenesis and cancer stem cells.
Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection
Increasing evidence suggests that use of cannabinoids as a new therapeutic target has been recommended as a promising therapy for Parkinson’s disease.